Examining the Volatility of Mesa Laboratories, Inc.’s (MLAB) Stock

In the past week, MLAB stock has gone down by -0.48%, with a monthly decline of -9.17% and a quarterly plunge of -5.13%. The volatility ratio for the week is 6.37%, and the volatility levels for the last 30 days are 4.50% for Mesa Laboratories, Inc. The simple moving average for the past 20 days is -6.66% for MLAB’s stock, with a -9.81% simple moving average for the past 200 days.

Is It Worth Investing in Mesa Laboratories, Inc. (NASDAQ: MLAB) Right Now?

The price-to-earnings ratio for Mesa Laboratories, Inc. (NASDAQ: MLAB) is above average at 567.35x, Company’s 36-month beta value is 0.82.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for MLAB is 5.21M, and currently, short sellers hold a 3.77% ratio of that floaft. The average trading volume of MLAB on April 03, 2024 was 51.07K shares.

MLAB) stock’s latest price update

Mesa Laboratories, Inc. (NASDAQ: MLAB)’s stock price has gone decline by -11.25 in comparison to its previous close of 112.00, however, the company has experienced a -0.48% decrease in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-01 that LAKEWOOD, Colo., April 01, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.

Analysts’ Opinion of MLAB

Many brokerage firms have already submitted their reports for MLAB stocks, with Evercore ISI repeating the rating for MLAB by listing it as a “Outperform.” The predicted price for MLAB in the upcoming period, according to Evercore ISI is $125 based on the research report published on January 04, 2024 of the current year 2024.

Evercore ISI, on the other hand, stated in their research note that they expect to see MLAB reach a price target of $300. The rating they have provided for MLAB stocks is “In-line” according to the report published on January 04th, 2021.

KeyBanc Capital Markets gave a rating of “Sector Weight” to MLAB, setting the target price at $287 in the report published on November 10th of the previous year.

MLAB Trading at -2.16% from the 50-Day Moving Average

After a stumble in the market that brought MLAB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.06% of loss for the given period.

Volatility was left at 4.50%, however, over the last 30 days, the volatility rate increased by 6.37%, as shares sank -11.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.97% upper at present.

During the last 5 trading sessions, MLAB fell by -0.48%, which changed the moving average for the period of 200-days by -26.83% in comparison to the 20-day moving average, which settled at $105.85. In addition, Mesa Laboratories, Inc. saw -5.13% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MLAB starting from Archbold Brian David, who sale 1,500 shares at the price of $112.36 back on Dec 15 ’23. After this action, Archbold Brian David now owns 558 shares of Mesa Laboratories, Inc., valued at $168,540 using the latest closing price.

Schmieder John Bradley, the Director of Mesa Laboratories, Inc., sale 1,000 shares at $123.74 during a trade that took place back on Sep 15 ’23, which means that Schmieder John Bradley is holding 62,760 shares at $123,740 based on the most recent closing price.

Stock Fundamentals for MLAB

Current profitability levels for the company are sitting at:

  • -0.04 for the present operating margin
  • 0.61 for the gross margin

The net margin for Mesa Laboratories, Inc. stands at 0.0. The total capital return value is set at -0.01. Equity return is now at value 0.24, with 0.13 for asset returns.

Based on Mesa Laboratories, Inc. (MLAB), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.59. The interest coverage ratio of the stock is -2.03.

Currently, EBITDA for the company is 3.32 million with net debt to EBITDA at 7.1. When we switch over and look at the enterprise to sales, we see a ratio of 3.5. The receivables turnover for the company is 5.91for trailing twelve months and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.68.


In a nutshell, Mesa Laboratories, Inc. (MLAB) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts